Controlled attenuation parameter using the FibroScan® XL probe for quantification of hepatic steatosis for non‐alcoholic fatty liver disease in an Asian population
2017 ◽
Vol 5
(1)
◽
pp. 76-85
◽
2020 ◽
Vol 39
(1)
◽
pp. 32-41
◽
2020 ◽
Vol 34
(3)
◽
pp. 107512
◽
2019 ◽
Vol 71
(2)
◽
pp. 183-188
◽